title: Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery.
abstract: BACKGROUND
  The aim of the study was to evaluate whether the phosphorylated isoforms of insulin-like growth factor-binding protein-1 (IGFBP-1), a protein produced by the decidua, can be detected in cervical secretions of pregnant women with preterm uterine contractions, and whether their presence predicts an increased risk of preterm delivery.
  
  
  METHODS
  A prospective analysis of sixty-three women who presented with preterm labor but intact fetal membranes at weeks 22-36+6 days of gestation at the Antenatal clinic at the Department of Obstetrics and Gynecology, Helsinki University Central Hospital. Phosphorylated IGFBP-1 (phIGFBP-1) was measured in cervical swab samples obtained at presentation, using an immunoenzymometric assay. The values > or =10 microg/L were considered as positive. In addition, 58 asymptomatic women at the same gestational stage were studied as controls. Multiple logistic regression was applied to control for confounding variables and to obtain adjusted odds ratios.
  
  
  RESULTS
  The concentration of phIGFBP-1 in cervical samples ranged from undetectable to 95 microg/L. In 17 of the 63 (27%) women with preterm labor it was > or =10 microg/L. Seven of these 17 (41%) women with a positive phIGFBP-1 result delivered preterm, all before 35 weeks of gestation. Among the women with preterm labor and a negative phIGFBP-1 result, three of the 46 (7%) delivered before 37 weeks of gestation (adjusted OR 24, 95% CI 1.2-487), but all after 35 weeks of gestation. In the asymptomatic control population three out of 58 (5%) women had a positive cervical phIGFBP-1 test result but none delivered preterm. Among the controls with a negative cervical phIGFBP-1 test result (55 of 58, 95%), one woman delivered preterm (1 of 55, 2%).
  
  
  CONCLUSIONS
  Pregnant women who are in preterm labor with intact fetal membranes and who have a positive phIGFBP-1 test result in cervical secretion have an increased risk of preterm delivery.
authors.affiliation: Department of Obstetrics and Gynecology, Helsinki University Central Hospital, and Medix Biochemica, Kauniainen, Finland.
authors.forename: M
authors.initials: M
authors.lastname: Kekki
authors.forename: T
authors.initials: T
authors.lastname: Kurki
authors.forename: T
authors.initials: T
authors.lastname: Kärkkäinen
authors.forename: V
authors.initials: V
authors.lastname: Hiilesmaa
authors.forename: J
authors.initials: J
authors.lastname: Paavonen
authors.forename: E M
authors.initials: EM
authors.lastname: Rutanen
mesh_terms: D000293:Adolescent; D000328:Adult; D015415:Biomarkers / Q000032:analysis; D016022:Case-Control Studies; D002584:Cervix Uteri / Q000737:chemistry* / Q000378:metabolism*; D016001:Confidence Intervals; D005260:Female; D005387:Finland; D005865:Gestational Age; D006801:Humans; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000032:analysis*; D016015:Logistic Models; D007752:Obstetric Labor, Premature / Q000175:diagnosis* / Q000453:epidemiology*; D016017:Odds Ratio; D011237:Predictive Value of Tests; D011247:Pregnancy; D011256:Pregnancy Outcome; D011446:Prospective Studies; D012016:Reference Values; D018570:Risk Assessment; D012494:Sampling Studies; D012680:Sensitivity and Specificity; D014590:Uterine Contraction / Q000502:physiology
chemical_list: D015415:Biomarkers; D018970:Insulin-Like Growth Factor Binding Protein 1